Document is current
Any future updates will be listed below
-
Authors
Bařinka, Jan
Hu, Zunsong
Wang, Lu https://orcid.org/0000-0002-0073-0666
Wheeler, David A.
Rahbarinia, Delaram
McLeod, Clay
Gu, Zhaohui https://orcid.org/0000-0003-1581-1327
Mullighan, Charles G. https://orcid.org/0000-0002-1871-1850
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA241297, CA021765, CA297695)
Leukemia and Lymphoma Society (Special Fellow)
American Society of Hematology (Scholar)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (GM115279)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
- License Information
-
More Information
Article History
Received: 12 November 2021
Revised: 3 March 2022
Accepted: 11 March 2022
First Online: 29 March 2022
Competing interests
: CGM has received consulting fees from Illumina, speaking fees from Amgen, and research support from Pfizer, Loxo Oncology and Abbvie
